IRCT20190210042676N6已完成2 期
Evaluation of safety and efficacy of Ahmadi anti-aging cream in skin rejuvenation and improving skin wrinkle
Javansaz Ahmadi Company0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 50 years（—）
- 性别
- All
入选标准
- •In terms of wrinkles, the skin should be grade 2 or 3 according to the Glogau scale.
- •Signing the consent form for participation in the study
排除标准
- •Volunteers should not use any cream other than sunscreen and moisturizer,during the study.
- •History of any type of cosmetic surgery over the past 3 years at the treatment site
- •History of using RF within the past year
- •History of botulinum toxin injection, laser or intense pulsed light within the past 6 months
- •Any immunodeficiency or use of immunosuppressive drugs (cancer, chronic liver and kidney disease, etc.)
- •Pregnancy or lactating
- •Active smoker in last 2 years
研究者
相似试验
招募中
不适用
Evaluation of the efficacy and safety of anti-allergic ophthalmic solution for the treatment of allergic conjunctivitis.Allergic conjunctivitisJPRN-UMIN000013073Mizoguchi Eye Clinic100
招募中
不适用
An evaluation of the efficacy and safety of anti-infective agent.infectionJPRN-UMIN000017224Keio University100
进行中（未招募）
1 期
se of an antidiabetic drug (Empagliflozin) to lower the blood level of 1,5-anhydroglucitol in patients deficient in the glucose-6-phosphate transporter (GSD1b) and the phosphatase G6PC3, both of the endoplasmic reticulum, to treat their recurrent infections by normalizing their blood neutrophil counts. Neutrophils are the most abundant white blood cells in our blood that are essential to help fighting infections. 1,5-anhydroglucitol is a sugar derivative with no known function.(1) Severe Congenital Neutropenia type 4 (SNC4) due to a deficiency in G6PC3, a phosphatase of the endoplasmic also known a Ubiquitous glucose-6-phosphatase and (2) the neutropenia in Glycogen Storage Disease type 1b due to a deficiency in the glucose-6-phosphate transporter (G6PT / SLC37A4) of the endoplasmic reticulum.EUCTR2018-004191-35-BECliniques universitaires Saint-Luc5
尚未招募
不适用
Comparative study of efficacy and safety of Administering 4mg once daily and 2mg twice daily of silodosin in patients with benign prostatic hyperplasiabenign prostatic hyperplasiaJPRN-UMIN000002188JR Tokyo General Hospital100
已完成
不适用
Safety and efficacy determinations of anti-aging products (CAFF, CADO and CANO) for combination to oily skiHealthy Thai female subjectsAnti agingskin irritationpatch testTCTR20181115003nilever thai services co. ltd33